Advertise
|
Contact
Home
News
Features
Events
Whitepapers
Webinars
Research
Jobs
Search:
Most Popular Stories
Most Read
Most Emailed
Latest News
J&J to invest $1B in Elan, scoops up drug program
Sanofi-Aventis wins big with Multaq approval
Doc-gift bans take effect in New England
Most profitable drugmaker? Not a Big Pharma
Eisai creates jobs, readies Aricept NDA
Pfizer, GSK's stop-smoking meds get warning
Even productive reps will be obsolete, PwC says
FierceBiotech's 2009 Fierce 15
Stem cells used to reverse MS symptoms
Top 20 venture capital deals of 2008
Top 5 Regions Targeting Biotech Companies - 2009
Analyst: Contract sales reps rule
Eisai creates jobs, readies Aricept NDA
King, Acura get FDA response letter
J&J to invest $1B in Elan, scoops up drug program
Sanofi-Aventis wins big with Multaq approval
Sepracor depression drug flunks a mid-stage test
Featured Jobs
Looking for Experienced Mechanical Engineer Manager (2344)
The Alpine Group - Washington, DC
Sr. Dir/Dir, Medical Affairs
Azur Pharma, Inc - Philadephia, PA
Program Executive
Prestige Scientific - Boston, MA
Clinical Research Manager
Prestige Scientific - NW of Boston, MA
Senior Director Business Development M&A
Philips Healthcare - Andover, MA
More Jobs >>
Webinars
Oncology Trials: Navigating the Regulatory Landscape
From the moment you file an IND application right through clinical development, oncology d
Moving from Task In-Sourcing to Comprehensive Outsourcing with CROs
In this webinar, we will discuss the evolving relationship between pharmaceutical sponsors
More Webinars >>
Popular Topics
FDA
Phase III
Biotech Venture Capital
pharmaceuticals
Phase II
GlaxoSmithKline
Mergers and Acquisitions
Pfizer
milestones
Merck
Novartis
Drug Trials
Deals
FDA approval
More tags...
Events
Project Management Training
August 23-26, 2009
—
San Diego, CA
Centric Health Resources Ultra Orphan Conference 2009
Aug 24-26
ADAPT Congress: Accelerating Development & Advancing Personalized Therapy
Sept 22-25
—
Washington, DC
10th Annual Generic Drugs Summit: Business of Biosimilars
Sept 23-25
—
Boston, MA
More Events >>
Free Newsletter
Free Daily FierceBiotech Newsletter:
About
|
View Sample
|
Privacy
Related Topics >>
Eli Lilly
|
Sidney Taurel
Eli Lilly CEO Sidney Taurel
October 3, 2007 — 9:27am ET | By
Maureen Martino
Free newsletter via e-mail
Related Stories
Lilly inks $300M R&D pact with Cadila
Lilly CEO 'hungry' for new buyouts
Altea inks deal for transdermal Byetta patch
Doctor demands halt to FDA review of Lilly's prasugrel
In speech, Lilly CEO calls for drug monitoring
Tools
Email
Print
Contact Author
Reprint
Click here to get the FierceBiotech email newsletter for FREE!
More stories about
Eli Lilly
Sidney Taurel
Click here to get the FierceBiotech email newsletter for FREE!